文献速递流行病学与生物统计临床试验与 GCP

带治疗选择的分组序贯多臂多阶段试验设计

Group sequential multi-arm multi-stage trial design with treatment selection.
PubMed 文献 · Stat Med · 2023-02-20

多臂试验可同时比较多种试验治疗与共同对照,较传统随机对照试验有显著效率优势。本文基于序贯条件概率比检验提出分组序贯多臂多阶段(MAMS)试验设计,对任意阶段数和臂数提供无效性与有效性边界的解析解,避免复杂计算。模拟结果显示,该方法相比Magirr等人在R包MAMS中实现的方法具有若干优势。

要点

  • 基于序贯条件概率比检验提出分组序贯MAMS设计,提供无效性与有效性边界的解析解。
  • 解析解适用于任意阶段数和臂数,避免复杂计算负担。
  • 模拟结果显示,该方法相比R包MAMS中Magirr等人的方法具有若干优势。

核心结论

  • 基于序贯条件概率比检验的分组序贯MAMS设计可为任意阶段数和臂数提供无效性与有效性边界的解析解,模拟结果显示其相比Magirr等人的方法具有若干优势。

研究设计与样本

  • 方法学研究,提出基于序贯条件概率比检验的分组序贯多臂多阶段试验设计,并通过模拟与Magirr等人在R包MAMS中实现的方法进行比较。

主要发现

  • 所提方法对任意阶段数和臂数均给出无效性与有效性边界的解析解。
  • 解析解避免了Magirr等人方法所需的复杂计算。
  • 模拟结果显示,所提方法相比R包MAMS中Magirr等人的方法具有若干优势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A multi-arm trial allows simultaneous comparison of multiple experimental treatments with a common control and provides a substantial efficiency advantage compared to the traditional randomized controlled trial. Many novel multi-arm multi-stage (MAMS) clinical trial designs have been proposed. However, a major hurdle to adopting the group sequential MAMS routinely is the computational effort of obtaining total sample size and sequential stopping boundaries. In this paper, we develop a group sequential MAMS trial design based on the sequential conditional probability ratio test. The proposed method provides analytical solutions for futility and efficacy boundaries to an arbitrary number of stages and arms. Thus, it avoids complicated computational effort for the methods proposed by Magirr et al. Simulation results showed that the proposed method has several advantages compared to the methods implemented in R package MAMS by Magirr et al.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Wu J, Li Y, Zhu L, et al. Group sequential multi-arm multi-stage trial design with treatment selection. Stat Med. 2023. PMID: 36808736. doi:10.1002/sim.9682

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。